Fortnightly Review: Insulin resistance
BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7069.1385 (Published 30 November 1996) Cite this as: BMJ 1996;313:1385- Andrew J Krentz, consultant physiciana
- Accepted 17 October 1996
Abstract
Summary points
Insulin resistance is a state in which normal concentrations of insulin produce a subnormal biological response
Patients with insulin resistance have hyperinsulinaemia together with normoglycaemia or hyperglycaemia
Insulin resistance is commonly associated with obesity, non-insulin dependent diabetes mellitus, and essential hypertension
The insulin resistance syndrome includes impaired insulin stimulated glucose uptake, hyperinsulinaemia, glucose intolerance, hypertension, and dyslipidaemia
Drugs such as corticosteroids, ß blockers, and high dose thiazides can exacerbate insulin resistance; angiotensin converting enzyme inhibitors and (alpha) blockers may reduce resistance
Reducing insulin resistance is important in managing non-insulin dependent diabetes—for example, by losing weight, aerobic exercise, and stopping smoking; moderate alcohol consumption improves insulin resistance
Metformin improves multiple aspects of the insulin resistance syndrome. Novel insulin action enhancing drugs including the thiazolidinediones are under evaluation
Footnotes
-
Conflict of interest None.
- Accepted 17 October 1996
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.